Vaccine Success Brings Jubilation

 

The world just got the greatest news possible. A vaccine developed by Pfizer has shown greater than 90% effectiveness in clinical trials.

The stock market literally went through the roof with this good news. After a nearly 2,000 point rise early in the day, the Dow Jones Industrial Average ended the day up 835 points. Nearly everyone greeted this news with celebration as it heralded the coming of a post-pandemic return to something approaching normal. Only New York Governor Andrew Cuomo could find something negative to say when he bemoaned this development came “too soon” since the distribution of the new vaccine would happen under the Trump administration rather than Democrat Joe Biden.

The Pfizer vaccine, developed with partner BioNTech SE of Germany, has been in Phase III trials using 44,000 test subjects. Half received the new vaccine and half received a placebo. Pfizer announced 94 subjects contracted the virus. The more than 90% efficacy rate suggests that most, if not all, of the 94 sick subjects had received the placebo. Pfizer expects to apply for Emergency Use Authorization (EUA) by the end of this month once it completes a two-month safety analysis.

This vaccine is based on a new technology using messenger RNA (mRNA) to elicit an immune response to the virus. This same technology is being used by Moderna in association with the National Institute of Allergy and Infectious Disease (NIAID). Moderna is also on track for an interim efficacy analysis and a two-month safety follow-up for at least half the people in its clinical trial this month.

The Wall Street Journal has produced the following graphic to explain how the vaccine works:

When will the vaccine be ready for authorization?

It is expected that Pfizer will apply for EUA at the end of this month. The FDA then must authorize use of the vaccine based on their consideration of its safety. No serious safety issues have been seen thus far. It is unclear when the FDA will grant EUA.

When will people start getting vaccinated?

If the FDA grants authorization, vaccination shots could begin before the end of the year. Pfizer expects to have 50 million doses available by then which is enough to vaccinate 25 million patients since two injections are necessary. Pfizer expects to have 1.3 billion doses produced in 2021.

What other vaccines are in development?

I mentioned the Moderna vaccine above. Others include the AstraZeneca, Johnson & Johnson, and Novavax vaccines, which are based on different technologies. All are in Phase III trials and could have results within the next few months. (see Vaccine Hope on the Way)

What don’t we know about the vaccine?

We don’t know its long-term effectiveness. We also don’t know whether it is effective in all age groups and across all various racial and ethnic groups.

It is hard to find something to criticize in this great announcement from Pfizer. I guess you have to be from New York.

Covid Mortality Rate Update

 

The media is obsessed with numbers. Every day for the last nine months we’ve been subjected to updates on the number of Covid-19 infections and the number of deaths.

There are two reasons for this obsession: they want us all to be fearful and they want Joe Biden to win the election. They want us all to be fearful because that gives them control over our lives. That increases our purchase of newspapers and keeps our eyeballs focused on television news. They want Joe Biden to win the election because they hate President Trump. By the time you read this, we may know if they succeeded.

But the larger issue concerns our fears. There are important questions to be answered. How dangerous is this Covid-19 pandemic? How much should we allow the media and our government to alter our lives? Is it dangerous enough to keep us from our work? Is it dangerous enough to keep our children out of school? Is it dangerous enough to keep us from worship in our churches?

If we’re talking about the common cold, the answer is obviously no. If we’re talking about the annual influenza season, the answer is the same, even though flu accounts for the death of between 25,000 and 80,000 Americans each year. No one every called for lockdowns and mask mandates even to prevent those deaths.

But the coronavirus known as Covid-19 has changed all that. Since it is new and therefore no one in the world has prior experience or exposure, there were many concerns about its unknown virulence. China lied about what they knew and the World Health Organization (WHO) promoted this disinformation. But the last nine months have answered some of those questions.

The WHO originally estimated the mortality rate at 3.4% in April. There were initial predictions of 500,000 deaths in the U.K. and up to 2.2 million deaths in the U.S. Over time these numbers were adjusted down to 100,000 – 240,000 deaths in the U.S. As I write this post, the world-wide death count has reached 1,206,866 and the U.S. death count is 236,501. With the number of Covid infections still rising (it will never actually decline), should we be worried?

A seroprevalence study in Santa Clara County, California in July estimated the true infection mortality rate somewhere between 0.12 – 0.2%. (Covid Mortality Rates Lower than Predicted) Others estimated the mortality rate between 0.3 – 1.5%. Most studies at that time put the rate between 0.5 and 1.0%.

Since July we have seen the development of improved therapeutics as evidenced by the rapid recovery of President Trump. An effective vaccine is likely only weeks to a few months from wide-spread dissemination. As the winter months approach, are we really looking at “a cold, dark winter” as Joe Biden predicts?

If you do the simple math of taking the number of deaths and dividing by the number of infections, you get the following results:

Country                                  Total Infections         Total Deaths              Mortality Rate

United States                            9,475,872                    236,501                        0.024%

Russia                                       1,655,038                    28,473                          0.023%

The World                              46,940,949                  1,206,866                       0.025%

 

Since influenza rates of infection and deaths are only estimates, based on doctor-treated illness and hospitalizations, the mortality rate of typical flu is difficult to calculate. The CDC estimates for the influenza season of 2018-2019 are shown below. According to this graphic, the mortality rate varies from 0.4 – 48.7/100,00, depending mostly on age.  This translates to overall mortality rates of 0.000004 to 0.0005 %. The highest mortality rate, as in Covid, is in the elderly population.

According to the Johns Hopkins Medical School, the WHO estimates 290,000 to 650,000 people die world-wide each year due to influenza. By these estimates, the current Covid pandemic has resulted in roughly twice as many deaths, or 1,206,866. This would make Covid approximately twice as lethal as a typical flu season.

However, the influenza mortality rates are based on loose estimates since little actual testing is done and there is no mandatory reporting requirement for influenza. A careful review of the tables above from the CDC shows estimates of 35 million cases based on approximately half as many actual medical visits, or only 16,520,350. The assumption by the CDC is that less than half of the number of influenza cases are reported.

By this methodology, the number of Covid-19 cases is roughly twice the number of those who tested positive. This is probably a very conservative number since the seroprevalence study of Santa Clara County estimated 50 to 85 times as many actual cases as known cases. If the actual number of cases is twice the number of positive tests reported, the mortality rate calculated above drops to 0.012% in the U.S. This number is almost exactly ten times lower than the previous estimate from the Santa Clara study of 0.12% – and they were estimating 50 times as many cases!

If you’ve gotten lost in all this statistical study, the take-home message is this: The Covid-19 virus is fatal in only about one to two in a thousand on average, and about one to two in a hundred in those elderly people who have other comorbidities such as heart disease, diabetes, lung disease, or obesity. Even these numbers are probably exaggerated since we know from anecdotal evidence that many deaths attributed to Covid were actually caused by other medical conditions.

Certainly, these numbers tell us Covid-19 is a significant threat to the elderly, especially those with comorbidities. They should be protected by all means possible. But if we had known this nine months ago, does anyone believe the world would have called for lockdowns and mask mandates for everyone?

Democrats Expand Medicaid to the Wealthy

 

Democrats have always believed in Medicaid. They pushed the expansion of Medicaid through the Affordable Care Act (ObamaCare) and even tried to force every state to comply. The Supreme Court struck down that part of the ACA, but they still managed to convince a majority of states to expand their Medicaid rolls by promising them 100% federal support for three years.

Still not content with that achievement, now they’re at it again, this time trying to expand Medicaid eligibility to those who make too much money. Remembering the liberal mantra, “Never let a crisis go to waste,” they are using the Covid pandemic to accomplish their goal.

Chris Jacobs, writing in The Wall Street Journal, tells us a coronavirus relief bill signed by President Trump on March 18 included a 6.2% increase in states’ Medicaid matching rates for the duration of the pandemic. But the additional dollars came with a big catch: States can terminate Medicaid enrollment during the public health emergency only if “the individual requests a voluntary termination of eligibility” or moves out of state. No increase in income or assets, no matter how great, permits a state to disenroll someone from Medicaid.

The Congressional Budget Office (CBO) believes the pandemic will increase Medicaid enrollment by about nine million in 2021, and spending by $86 billion, next year compared to its March pre-Covid projections. The CBO estimates that “about half of the projected increase in enrollment . . . results from the new requirement that states allow people to remain enrolled in Medicaid longer,” meaning approximately 4.5 million otherwise ineligible people will remain on the rolls.

Jacobs tells us how this can impact a state by relating the Louisiana experience. Early last year, following an audit that showed people earning over $145,000 a year remained on Medicaid, the state began checking income eligibility on a quarterly basis. The audits led to the removal of 30,000 from Medicaid – including at least 1,672 with income of over $100,000 – saving taxpayers some $400 million.

But now with the Congress imposing the maintenance-of-effort provisions this spring, enrollment in Louisiana’s Medicaid expansion has exploded. From March through September, enrollment surged 16.5%, or more than 78,000, to reach all-time highs. The CBO’s assumption that the maintenance-of-effort requirements explain half of the enrollment increase suggests approximately 40,000 Louisianans have remained on expanded Medicaid after becoming ineligible – more than the state removed from the rolls last year.

To be sure, some would argue this is reasonable on a temporary basis to cope with the Covid pandemic. But that wouldn’t be enough for House Speaker Pelosi. She pushed through an ObamaCare “enhancement” bill that would require states to keep individuals continuously enrolled in Medicaid for 12 months before checking eligibility, at a cost to taxpayers of nearly $205 billion over 10 years.

If this were only about providing healthcare for people in need, I might support it. But Medicaid is the worst form of healthcare in this country, even worse than having no insurance at all, because it reduces access to healthcare. I have written extensively on this subject all the reasons this is true in this blog and in my book, The ObamaCare Reality.

Furthermore, the expansion of Medicaid not only increases our federal deficit, it saddles states with difficult budgetary choices between providing Medicaid versus education, law enforcement, and infrastructure. Jacobs summarizes, “With federal debt soaring, neither states nor Washington can afford to keep ineligible individuals on the Medicaid rolls. Democrats are showing the fiscally irresponsible nature of their drive to expand the welfare state.”